| scholarly article | Q13442814 |
| P50 | author | James Lyons-Weiler | Q48080773 |
| P2093 | author name string | Joseph M Pilewski | |
| Carol A Feghali-Bostwick | |||
| Haiwen Shi | |||
| Rick M Jordan | |||
| Eileen Hsu | |||
| P2860 | cites work | Functional characterization of podocan, a member of a new class in the small leucine-rich repeat protein family | Q24323597 |
| Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 | ||
| GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies | Q24801173 | ||
| Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblasts | Q24804612 | ||
| Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis | Q28209836 | ||
| Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein/thionein | Q28509018 | ||
| Gene expression profiling of pulmonary fibrosis identifies Twist1 as an antiapoptotic molecular "rectifier" of growth factor signaling | Q28571857 | ||
| Java Treeview--extensible visualization of microarray data | Q29547226 | ||
| Open source clustering software | Q29547702 | ||
| Deficiency in the LIM-only protein Fhl2 impairs skin wound healing | Q30480424 | ||
| Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). | Q31037121 | ||
| Primary pulmonary hypertension. A national prospective study | Q33169642 | ||
| Microarray data analysis: from disarray to consolidation and consensus | Q33230059 | ||
| Molecular subsets in the gene expression signatures of scleroderma skin | Q33354088 | ||
| Therapy for pulmonary arterial hypertension associated with systemic sclerosis | Q33805746 | ||
| Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans | Q34028910 | ||
| Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition | Q35083605 | ||
| Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis | Q35748291 | ||
| Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis | Q35749152 | ||
| Gene expression profiling of familial and sporadic interstitial pneumonia | Q35855118 | ||
| Changes in causes of death in systemic sclerosis, 1972-2002 | Q35954516 | ||
| Systemic and cell type-specific gene expression patterns in scleroderma skin | Q36349808 | ||
| Identification of candidate genes in scleroderma-related pulmonary arterial hypertension | Q36608862 | ||
| Efficiency analysis of competing tests for finding differentially expressed genes in lung adenocarcinoma. | Q37055963 | ||
| Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway. | Q37073709 | ||
| Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival | Q37135029 | ||
| Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis | Q37336586 | ||
| Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trials | Q37417760 | ||
| Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee | Q39513167 | ||
| Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients | Q41179330 | ||
| Nitric-oxide-mediated zinc release contributes to hypoxic regulation of pulmonary vascular tone | Q42540322 | ||
| caGEDA: a web application for the integrated analysis of global gene expression patterns in cancer. | Q42674587 | ||
| Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis | Q47948256 | ||
| Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. | Q51713531 | ||
| Preliminary criteria for the classification of systemic sclerosis (scleroderma) | Q54165663 | ||
| Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles. | Q54638915 | ||
| Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts | Q60537787 | ||
| Insulin-like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosis | Q64377525 | ||
| Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography | Q68892769 | ||
| Gene expression in bronchoalveolar lavage cells from scleroderma patients | Q77995648 | ||
| Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension | Q80236856 | ||
| P433 | issue | 3 | |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| P304 | page(s) | 783-794 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension | |
| P478 | volume | 63 |
| Q91868661 | 18F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease-A Proof-of-Concept Study |
| Q64249960 | A Human Skin Model Recapitulates Systemic Sclerosis Dermal Fibrosis and Identifies COL22A1 as a TGFβ Early Response Gene that Mediates Fibroblast to Myofibroblast Transition |
| Q58700783 | A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement |
| Q35207651 | A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis |
| Q37717578 | A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis. |
| Q35628723 | Association of Interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis. |
| Q37905787 | Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling |
| Q35077927 | Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis |
| Q61894832 | Clinical Assessment of Pulmonary Hypertension |
| Q90032341 | Cross-Talk between Transforming Growth Factor-β and Periostin Can Be Targeted for Pulmonary Fibrosis |
| Q38156227 | Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development |
| Q37209512 | Cytokine mediated tissue fibrosis |
| Q61811653 | Dendritic Cell Subsets and Effector Function in Idiopathic and Connective Tissue Disease-Associated Pulmonary Arterial Hypertension |
| Q33820556 | Differences in irradiated lung gene transcription between fibrosis-prone C57BL/6NHsd and fibrosis-resistant C3H/HeNHsd mice |
| Q30845649 | Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis |
| Q26852090 | Dust events, pulmonary diseases and immune system |
| Q39100245 | Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis |
| Q36888302 | Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension |
| Q33738546 | Estrogen receptor-dependent attenuation of hypoxia-induced changes in the lung genome of pulmonary hypertension rats |
| Q27025625 | Evolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genes |
| Q92060214 | Excessive exosome release is the pathogenic pathway linking a lysosomal deficiency to generalized fibrosis |
| Q39678375 | Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies |
| Q28083733 | Gene expression profiling offers insights into the role of innate immune signaling in SSc |
| Q37400152 | Genetic architecture of human fibrotic diseases: disease risk and disease progression |
| Q58122025 | IGFBP-5 Promotes Fibrosis via Increasing Its Own Expression and That of Other Pro-fibrotic Mediators |
| Q89749921 | IPF pathogenesis is dependent upon TGFβ induction of IGF-1 |
| Q52578942 | Impact of Transcriptomics on Our Understanding of Pulmonary Fibrosis. |
| Q35923173 | Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: possible role of Th17 cells in chronic lung pathology |
| Q64966018 | Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases. |
| Q93089254 | Insulin-like growth factor binding protein-4 exerts antifibrotic activity by reducing levels of connective tissue growth factor and the C-X-C chemokine receptor 4 |
| Q38026844 | Insulin-like growth factor binding proteins-3 and -5: central mediators of fibrosis and promising new therapeutic targets. |
| Q35106452 | Integrating mechanisms of pulmonary fibrosis |
| Q36810797 | Integrating molecular genetics and systems approaches to pulmonary vascular diseases |
| Q46474228 | Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement |
| Q58785737 | Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1 |
| Q35644609 | Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension |
| Q38255323 | Interstitial lung disease in connective tissue disease--mechanisms and management |
| Q47372819 | Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review |
| Q46011006 | Leukotriene C4 aggravates bleomycin-induced pulmonary fibrosis in mice. |
| Q50499077 | Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll-like receptor response: another role for CXCL4? |
| Q38678295 | Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence? |
| Q90966606 | Major lung complications of systemic sclerosis |
| Q26799573 | Management of Systemic-Sclerosis-Associated Interstitial Lung Disease |
| Q37364008 | Matrix Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation. |
| Q33745690 | Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humans |
| Q39204642 | Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms |
| Q41412898 | MicroRNA-21 in scleroderma fibrosis and its function in TGF-β-regulated fibrosis-related genes expression |
| Q26748607 | Microarray analysis in pulmonary hypertension |
| Q37112937 | Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease. |
| Q38220769 | Molecular biomarkers in interstitial lung diseases. |
| Q36130791 | Molecular network of important genes for systemic sclerosis-related progressive lung fibrosis |
| Q38772739 | Myeloid Populations in Systemic Autoimmune Diseases. |
| Q37635850 | Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-β1 signaling in interstitial lung disease |
| Q34019921 | Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings |
| Q89450048 | Periostin plays a critical role in the cell cycle in lung fibroblasts |
| Q38206152 | Personalized medicine in systemic sclerosis: facts and promises |
| Q26866919 | Personalized medicine: applying 'omics' to lung fibrosis |
| Q90639907 | Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis |
| Q36096312 | RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension. |
| Q35121494 | Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct? |
| Q33919119 | Scleroderma lung disease |
| Q58773943 | Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis |
| Q34721223 | Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis |
| Q37503878 | Skin gene expression correlates of severity of interstitial lung disease in systemic sclerosis |
| Q39029340 | Systematic approach to understanding the pathogenesis of systemic sclerosis. |
| Q60927643 | Systems Analysis of Transcriptomic and Proteomic Profiles Identifies Novel Regulation of Fibrotic Programs by miRNAs in Pulmonary Fibrosis Fibroblasts |
| Q38601631 | T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review |
| Q37662888 | The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin |
| Q36629436 | The effect of environmental enrichment on substantia nigra gene expression after traumatic brain injury in rats |
| Q56763247 | The mechanistic implications of gene expression studies in SSc: Insights from Systems Biology |
| Q49511487 | Thinking BIG rheumatology: how to make functional genomics data work for you. |
| Q47656873 | Transcriptomic evidence of immune activation in macroscopically normal-appearing and scarred lung tissues in idiopathic pulmonary fibrosis |
| Q50925712 | Transforming growth factor β1 (TGFβ1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts. |
| Q37638268 | Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities |
| Q27016132 | Update on scleroderma-associated interstitial lung disease |
| Q55286414 | Using Omics to Understand and Treat Pulmonary Vascular Disease. |
| Q28385088 | Validated prediction of pro-invasive growth factors using a transcriptome-wide invasion signature derived from a complex 3D invasion assay |
| Q38141638 | What does global gene expression profiling tell us about the pathogenesis of systemic sclerosis? |
| Q37064457 | miR-155 in the progression of lung fibrosis in systemic sclerosis. |
| Q37925433 | β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target |
Search more.